# A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug

> **NCT00382668** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 40 (estimated)

## Conditions studied

- Liver Diseases

## Interventions

- **DRUG:** Dasatinib
- **DRUG:** Dasatinib
- **DRUG:** Dasatinib

## Key facts

- **NCT ID:** NCT00382668
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00382668

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00382668, "A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00382668. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*